Appetite and gastrointestinal motility: Role of ghrelin-family peptides

Clinical Nutrition

Volumn 29, Issue 2, 2010, Pages 227-234

  Perboni, Simona ^a   Inui, Akio ^b  

^a Hospital of Desenzano del Garda   (Italy)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Appetite; Gastrointestinal motility; Ghrelin; Obestatin

Indexed keywords

CHOLECYSTOKININ; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; CORTICOTROPIN; GHRELIN; GHRELIN RECEPTOR; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GROWTH HORMONE; GROWTH HORMONE SECRETAGOGUE RECEPTOR; INSULIN; LEPTIN; LIPID; NEUROPEPTIDE Y; OBESTATIN; PEPTIDE YY; PROLACTIN; THYROTROPIN;

APPETITE; ARTICLE; CACHEXIA; EATING DISORDER; ENERGY BALANCE; FOOD INTAKE; GASTROINTESTINAL MOTILITY; GLUCOSE METABOLISM; HORMONE ACTION; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; HUNGER; LIPID METABOLISM; MORBID OBESITY; NONHUMAN; OBESITY; ROUX Y ANASTOMOSIS; STOMACH ACID SECRETION; STOMACH BYPASS; STOMACH MOTILITY; THERAPY EFFECT; WEIGHT REDUCTION;

ANIMALS; APPETITE; DIET; ENERGY METABOLISM; GASTROINTESTINAL MOTILITY; GHRELIN; HUMANS; LEPTIN; PEPTIDE HORMONES; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 77950297954     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2008.10.016     Document Type: Article

References (140)

1. Zigman J.M., Elmquist J.K. Minireview: from anorexia to obesity - the yin and yang of body weight control. Endocrinology 2003, 144:3749-3756.
2. Kojima M., Hosoda H., Date Y., et al. Ghrelin is a growth-hormone releasing acylated peptide from stomach. Nature 1999, 402:656-660.
3. 14-Ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. J Biol Chem 2000, 275:1995-2000.
4. Hosoda H., Kojima M., Matsuo H., Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 2000, 279:909-913.
5. Zhang J.V., Ren P.-G., Avsian-Kretchmer O., Luo C.-W., Rauch R., Klein C., Hsueh A.J. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005, 310:996-999.
6. Duggan J.P., Booth D.A. Obesity, overeating, and rapid gastric emptying in rats with ventromedial hypothalamic lesions. Science 1986, 231:609-611.
7. Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clinic 2002, 52:72-91.
8. Inui A. Cancer anorexia-cachexia syndrome: are neuropeptides the key?. Cancer Res 1999, 59:4493-4501.
9. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Ueno N., Makino S., Fujimiya M., Niijima A., Fujino M.A., Kasuga M. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001, 120:337-345.
10. Kojima M., Hosoda H., Matsuo H., Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 2001, 12:118-122.
11. Hosoda H., Kojima M., Kangawa K. Ghrelin and the regulation of food intake and energy balance. Molec Interventions 2002, 2:450-494.
12. Gauna G., Delhanty P.J.D., Hofland L.J., et al. Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J Clin Endocrinol Metab 2005, 90:1055-1060.
13. Thompson N.M., Gill D.A.S., Davies R., et al. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1 growth hormone secretagogue receptor. Endocrinology 2004, 145:234-242.
14. Mondal M.S., Date Y., Yamaguchi H., et al. Identification of ghrelin and its receptor in neurons of the rat accurate nucleus. Regul Pept 2006, 126:55-59.
15. Sato T., Fukue Y., Teranishi H., et al. Molecular forms of hypothalamic ghrelin and its regulation by fasting and 2-deoxy-d-glucose administration. Endocrinology 2005, 146:510-516.
16. Nakazato M, Muratami N, Date Y, Kojima M et al. A role for ghrelin in the central regulation of feeling, 2001; 409:194-198.
17. Horvath T.L., Diano S., Sotonyi P., Heiman M., Tschop M. Minireview: ghrelin and the regulation of energy balance - an hypothalamic perspective. Endocrinology 2001, 142:4163-4169.
18. Date Y., Kojima M., Hosoda H., et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000, 141:4255-4261.
19. Asakawa A., Inui A., Fujimiya M., et al. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 2005, 54:18-24.
20. Date Y., Marakami N., Toshinai K., Matsukura S., Nijima A., Matsuo H., Kangawa K., Nakazato M. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002, 123:1120-1128.
21. Beaumont N.J., Skinner V.O., Tan T.M., et al. Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase. J Biol Chem 2003, 278:8877-8880.
22. Nishi Y., Hiejima H., Hosoda H., et al. Ingested medium-chain fatty acids are directly utilized for the acyl modification of ghrelin. Endocrinology 2005, 146:2255-2264.
23. Patterson M., Murphy K.G., le Roux C.W., et al. Characterization of ghrelin-like immunoreactivity in human plasma. J Clin Endocrinol Metab 2005, 90:2205-2211.
24. Banks W.A., Tschop M., Robinson S.M., et al. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 2002, 302:822-827.
25. Kamegai J., Tamura H., Shimizu T., et al. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology 2000, 141:4797-4800.
26. Korbonits M., Bustin S.A., Kojima M., et al. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J Clin Endocrinol Metab 2001, 86:881-887.
27. Papotti M., Ghe C., Cassoni P., et al. Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab 2000, 85:3803-3807.
28. Shuto Y., Shibasaki T., Wada K., Parhar I., Kamegai J., Suhihara H., Okikawa S., Wakabayashi I. Generation of polyclonal antiserum against the growth hormone secretagogue receptor (GHS-R): evidence that the GHS-R exists in the hypothalamus, pituitary and stomach of the rats. Life Sci 2001, 68:991-996.
29. Rindi G., Torsello A., Locatelli V., Solcia E. Ghrelin expression and actions: a novel peptide for an old cell type of the diffuse endocrine system. Exp Biol Med 2004, 229:1007-1016.
30. Takaya K., Ariyasu H., Kanamoto N., Iwakura H., et al. Ghrelin strongly stimulates growth hormone (GH) release in humans. J Clin Endocinol Metab 2000, 85:4908-4911.
31. Peino R., Baldelli R., Rodriguez-Garcia J., et al. Ghrelin-induced growth hormone secretion in humans. Eur J Endocrinol 2000, 143:R11-R14.
32. Wren A.M., Small C.J., Ward H.L., Murphy K.G., et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000, 141:4325-4328.
33. Muccioli G., Tschop M., Papotti M., Deghenghi R., Heiman M., Ghigo E. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol 2002, 440:235-254.
34. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001, 86:5992-5995.
35. Tschöp M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature 2000, 407:908-913.
36. Masuda Y., Tanaka T., Inomata N., et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 2000, 276:905-908.
37. Inui A. Ghrelin: an orexigenic and somatotrophic signal from the stomach. Nat Rev Neurosci 2001, 2:551-560.
38. Inui A., Asakawa A., Bowers C.Y., et al. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J 2004, 18:439-456.
39. Curie P.J., Mirza A., Fuld R., Park D., Vasselli J.R. Ghrelin is an orexigenic and metabolic signaling peptide in the arcuate and paraventricular nuclei. Am J Physiol Regul Comp Physiol 2005, 2:R353-R358.
40. Kamegai J., Tamura H., Shimizu T., et al. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and agouti-related protein MRNA levels and body weight in rats. Diabetes 2001, 50:2438-2443.
41. Shintani M., Ogawa Y., Ebihara K., et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001, 50:227-232.
42. Cowley M.A., Grove K.L. Ghrelin. Satisfying a hunger for the mechanism. Endocrinology 2004, 145:2604-2606.
43. Dornonville de la Cour C., Lindqvist A., Egecioglu E., et al. Ghrelin treatment reverses the reduction in weight gain and body fat in gastrectomised mice. Gut 2005, 54:907-913.
44. le Roux C.W., Neary N.M., Halsey T.J., Small C.J., Martinez-Isla A.M., Ghatei M.A., Theodorou N.A., Bloom S.R. Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab 2005, 90:4521-4524.
45. Williams D.L., Cummings D.E. Regulation of ghrelin in physiologic and pathophysiologic states. J Nutr 2005, 13:1320-1325.
46. delParigi A., Tschop M., Heiman M.L., Salbe A., et al. High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader-Willi syndrome. J Clin Endocrinol Metabol 2002, 87:5461-5464.
47. Ariyasu H., Takaya K., Tagami T., et al. Stomach is a major source of circulating ghrelin and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001, 86:4573-4578.
48. Schmid D.A., Held K., Ising M., et al. Ghrelin stimulates appetite, imagination of food, GH, ACTH and cortisol, but does nor affect leptin in normal control. Neuropsychopharmacology 2005, 30:1187-1192.
49. Sanchez J., Oliver P., Palou A., et al. The inhibition of gastric production by food intake in rats is dependent on the type of macronutrient. Endocrinology 2004, 145:5049-5055.
50. Akamizu T., Takaya K., Irako T., et al. Pharmacokinetics, safety and endocrine and appetite effects of ghrelin administration in young healthy subjects. Eur J Endocrinol 2004, 150:447-455.
51. Worthley K.E., Anderson K.D., Garcia K., Murray J.D., Malinova L., Liu R. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci USA 2004, 101:8227-8232.
52. Overduin J., Frayo R.S., Grill H.J., et al. Role of the duodenum and macronutrient type in ghrelin regulation. Endocrinology 2005, 140:845-850.
53. Murakami N., Hayashida T., Kuroiwa T., et al. Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats. J Endocrinol 2002, 174:283-288.
54. Toshinai K., Mandal M.S., Nakazato M., et al. Up-regulation of ghrelin expression in the stomach upon fasting, insulin-induced hypoglicemia, and leptin administration. Biochem Biophys Res Commun 2001, 281:1220-1225.
55. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001, 50:1714-1719.
56. Tschöp M., Wawarta R., Riepl R.S., et al. Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 2001, 24:RC19-RC21.
57. Cummings D.E., Frayo R.S., Marmonier C., Aubert R., Chapelot D. Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. Am J Physiol Endocrinol Metab 2004, 287:E297-E304.
58. Cummings D.E., Schwartz M.W. Genetics and pathophysiology of human obesity. Annu Rev Med 2003, 54:453-471.
59. Drazen L.D., Vahl T.P., D'Alessio D.A., et al. Effects of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status. Endocrinology 2006, 147:23-30.
60. Tack J., Depoortere I., Bisschops R., Verbeke K., Janssens J., Peeters T. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther 2005, 22:847-853.
61. Peteers T.L. Central and peripheral mechanisms by which ghrelin regulates gut motility. J Physiol Pharmacol 2003, 54:95-103.
62. Fujino K., Inui A., Asakawa A. Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol 2003, 550:227-240.
63. Tebbe J.J., Mronga S., Tebbe C.G., et al. Ghrelin-induced stimulation of colonic propulsion is dependent on hypothalamic neuropeptide Y1-and corticotrophin-releasing factor 1 receptor activation. J Neuroendocrinol 2005, 17:570-576.
64. Tebbe J.J., Tebbe C.G., Mronga S., et al. Central neuropeptide Y receptors are involved in 3rd ventricular ghrelin induced alteration of colonic transit time in conscious fed rats. BMC Gastroenterol 2005, 5:5.
65. Murray C.D., Martin N.M., Patterson M., Taylor S.A., Ghatei M.A., Kamm M.A., Johnston C., Bloom S.R., Emmanuel A.V. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 2005, 54:1693-1698.
66. Sibilia V., Pagani F., Guidobono F., Locatelli V., Torsello A., Deghenghi R., Netti C. Evidence for a central inhibitory role of growth hormone secretagogues and ghrelin on gastric acid secretion in conscious rats. Neuroendocrinology 2002, 75:92-97.
67. Kobelt P., Tebbe J.J., Tjandra I., et al. CCK inhibits the orexigenic effect of peripheral ghrelin. AM J Physiol Regul Integr Comp Physiol 2005, 288:R751-R758.
68. Callahan H.S., Cummings D.E., Pepe M.S., et al. Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans. J Clin Endocrinol Metab 2004, 89:1319-1324.
69. Prodam F., Me E., Riganti F., et al. The nutritional control of ghrelin secretion in humans: the effects of enteral vs parenteral nutrition. Eur J Nutr 2006, 45:399-405.
70. Paul D.R., Kramer M., Rhodes D.G., Rumpler W.V. Preprandial ghrelin is not affected by macronutrient intake, energy intake or energy expenditure. J Negative Results Biomed 2005, 4:2-10.
71. Leydi H.J., Gardneer J.K., Frye B.R., et al. Circulating ghrelin is sensitive to changes in body weight during a diet and exercise program in normal-weight young women. J Clin Endocrinol Metab 2004, 89:1319-1324.
72. Broglio R., Arvat E., Benso A., et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 2001, 86:5083-5086.
73. Caixas A., Bashore C., Nash W., Pi-Sunyer F.X., LaFerrere B. Insulin, unlike food intake, does not suppress ghrelin in human subjects. J Clin Endocrinol Metab 2002, 87:1902-1906.
74. Schaller G., Schmidt A., Plainer J., et al. Plasma ghrelin concentrations are not regulated by glucose or insulin: a double blind, placebo controlled crossover clamp study. Diabetes 2003, 52:16-20.
75. Soriano-Guillen L., Barrio V., Martos G., et al. Effect of oral glucose administration on ghrelin levels in obese children. Eur J Endocrinol 2004, 151:119-121.
76. Shiiya T., Nakazato N., Isobe T., et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002, 87:240-244.
77. Murdolo G., et al. Insulin is required for prandial ghrelin suppression in humans. Diabetes 2003, 52:2923-2927.
78. Maffeis C., Bonadonna R.C., Consolaro A., et al. Ghrelin, insulin sensitivity and postprandial glucose disposal in overweight and obese children. Eur J Endocrinol 2006, 154:61-68.
79. Katsuki A., Urakawa H., Gabazza E.C., et al. Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus. Eur J Endocrinol 2004, 151:573-577.
80. Anderwald C., Brabant G., Bernoider E., et al. Insulin-dependent modulation of plasma ghrelin and leptin concentration is less pronounced in type 2 diabetic patients. Diabetes 2003, 52:1792-1798.
81. Tschöp M., Weyer C., Tataranni P.A., et al. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001, 50:707-709.
82. Baldelli R., Bellone S., Castellino N., et al. Oral glucose load inhibits ghrelin levels to the same extent in normal and obese children. Clin Endocrinol 2006, 64:255-259.
83. Shimizu Y., Nagaya N., Isobe T., et al. Increased plasma level in lung cancer cachexia. Clin Cancer Res 2001, 9:774-778.
84. Nagaya N., Uematsu M., Kojima M., et al. Elevated circulating level of ghrelin in cachexia associate d with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation 2001, 104:2034-2038.
85. Otto B., Cuntz U., Fruehauf E., Wawarta R., et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 2001, 145:R5-R9.
86. Cummings D.E., Weigle D.S., Frayo R.S., et al. Plasma ghrlin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002, 346:1623-1630.
87. Hellstrom M., Geliebter A., Naslund E., Schmidt P.T., Yahav E.K., Hashim S.A., Yeomans M.R. Peripheral and central signals in the control of eating in normal, obese and binge-eating human subjects. Br J Nutr 2004, 92:S47-S57.
88. Nakai Y., Hosoda H., Nin K., et al. Plasma levels of active form of ghrelin during oral glucose tolerance test in patients with anorexia nervosa. Eur J Endocrinol 2003, 149:R1-R3.
89. Mun E.C., Blackburn G.L., Matthews J.B. Current status of medical and surgical therapy for obesity. Gastroenterology 2002, 120:669-681.
90. Cummings D.E., Shannon M.H. Ghrelin and gastric bypass: is there a hormonal contribution to surgical weight loss?. J Clin Endocrinol Metab 2003, 88:2999-3002.
91. Tritos N.A., Mun E., Betkau A., et al. Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery. Obes Res 2003, 11:919-924.
92. Korner J., Bessler M., Cirilo L.J., et al. Effects of Roux-en Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY and insulin. J Clin Endocrinol Metab 2005, 90:359-365.
93. Williams D.L., Grill H.J., Cummings D.E., et al. Vagotomy dissociated short- and long-term controls of circulating ghrelin. Endocrinology 2003, 144:5184-5187.
94. Faraj M., Havel P.J., Phelis S., et al. Plasma acylation-stimulating protein, adiponectin, leptin and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2003, 88:1594-1602.
95. Stoeckli R., Chanda R., Langer I., et al. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res 2004, 12:346-350.
96. Holdstock C., Engstrom B.E., Ohrvall M., et al. Ghrelin and adipose tissue regulatory peptides: effects of gastric bypass surgery in obese humans. J Clin Endocrinol Metab 2003, 88:3177-3183.
97. Weigle D.S., Cummings D.E., Newby P.D., et al. Roles of leptin and ghrelin in the loss of body weight caused by a low fat, high carbohydrate diet. J Clin Endocrinol Metab 2003, 88:1577-1586.
98. Wynne K., Stanley S., Bloom S. The gut and regulation of body weight. J Clin Endocrinol Metab 2004, 89:2576-2582.
99. Kalra S.P., Bagnasco M., Otukonyong E.E., et al. Rhytmic, reciprocal ghrelin and leptin signaling: new insight in the development of obesity. Regul Pept 2003, 111:1-11.
100. Kalra S.P., Kalra P.S., Neuropeptide Y. a physiological orexigen modulated by the feedback action of ghrelin and leptin. Endocrine 2004, 22:49-56.
101. Bagnasco M., Kalra P.S., Kalra S.P. Ghrelin and leptin pulse discharge in fed and fasted rats. Endocrinology 2002, 143:726-729.
102. Barazzoni R., Zanetti M., Stebel M., et al. Hyperleptinemia prevents increased plasma ghrelin concentration during short-term moderate caloric restriction in rats. Gastroenterology 2003, 124:1188-1192.
103. Kalra S.P., Dube M.G., Pu S., et al. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 1999, 20:68-100.
104. Ueno N., Dube M.G., Inui A., et al. Leptin modulates orexigenic effects of ghrelin and attenuates adiponectin and insulin levels and selectively the dark-phase feeding as revealed by central leptin gene therapy. Endocrinology 2004, 145:4176-4184.
105. Weigle D.S., Breen P.A., Matthys C.C., et al. A high-protein diet induces sustained reductions in appetite, ad libitum caloric intake and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations. Am J Clin Nutr 2005, 82:41-48.
106. Chan J.L., Bullen J., Lee J.H., et al. Ghrelin levels are not regulated by recombinant leptin administration and/or three days of fasting in healthy subjects. J Clin Endocrinol Metab 2004, 89:335-343.
107. Asakawa A., Inui A., Kaga T., et al. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 2003, 52:947-952.
108. Chen C.Y., Chao Y., Chang F.Y., et al. Intracisternal des-acyl ghrelin inhibits food intake and non-nutrient gastric emptying in conscious rats. Int J Mol Med 2005, 16:695-699.
109. Toshinai K., Yamaguchi H., Sun Y., et al. Des-acyl ghrelin induced food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 2006, 147:2306-2314.
110. Matsumoto M., Hosoda H., Kitajima Y., et al. Structure-activity relationship of ghrelin: pharmacological study of ghrelin peptides. Biochem Biophys Res Comun 2001, 287:142-146.
111. Broglio F., Gottero C., Prodam F., et al. Non-acylated ghrelin counteracts the metabolic but not neuroendocrine response to acylated ghrelin in humans. J Endocrinol Invest 2004, 89:3062-3065.
112. Akamizu T., Shimomiya T., Irako T., et al. Separate measurement of plasma levels of acylated and desacylated ghrelin in healthy subjects using a new direct ELISA assay. J Clin Endocrinol Metab 2005, 90:6-9.
113. Ariyasu H., Takaya K., Iwakura H., et al. Transgenic mice overexpressing des-acyl ghrelin show small phenotype. Endocrinology 2005, 146:355-364.
114. Balzani G., Filigheddu N., Cutrupi S., et al. Ghrelin and de-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 2004, 159:1029-1037.
115. Cassoni P., Papotti M., Ghe C., et al. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. Eur J Endocrinol 2001, 150:173-184.
116. Cassoni P., Ghe C., Marrocco T., et al. Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell line. Eur J Endocrinol 2004, 150:173-184.
117. Muccioli G., Pons N., Ghe C., et al. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1 growth hormone secretagogue receptor. Eur J Pharmacol 2004, 498:27-35.
118. Chen C.Y., Inui A., Asakawa A., et al. Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology 2005, 129:8-25.
119. Gauna C., Meyler F.M., Janssen M.J.L., et al. Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J Clin Endocrinol Metab 2004, 89:5035-5042.
120. Lucidi P., Murdolo G., di Loreto C., et al. Metabolic and endocrine effects of physiological increments in plasma ghrelin concentrations. Nutr Metab Cardiovasc Disease 2005, 15:410-417.
121. Gauna C., Meyler F.M., Janssen J.A., et al. Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J Clin Endocrinol Metab 2004, 89:5035-5042.
122. Dun S.L., Brailoiu G.C., Brailoiu E., et al. Distribution and biological activity of obestatin in the rat. J Endocrinol 2006, 191:481-489.
123. Bresciani E., Rapetti D., Dona F., et al. Obestatin inhibits feeling but does not modulate GH and corticosterone secretion in the rat. J Endocrinol Invest 2006, 29:RC16-RC18.
124. Moechars D., Depoortere I., Moreaux B., et al. Altered gastrointestinal and metabolic function in the GPR39-obesatin receptor-knockout mouse. Gastroenterology 2006, 131:1131-1141.
125. Jackson V.R., Nothacker H.P., Civelli O. GPR39 receptor expression in the mouse brain. Neuroreport 2006, 17:813-816.
126. Nogueiras R., Tschop M. Separation of conjoined hormones yields appetite rivals. Science 2005, 310:985-986.
127. Yamamoto D., Ikeshita N., Daito R., et al. Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ACTH, despite the presence of GHRP39 in the pituitary of rats. Regul Pept 2007, 138:141-144.
128. Holst B., Egerod K.L., Schild E., et al. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 2007, 148:13-20.
129. Bassil A.K., Haglund Y., Brown J., et al. Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract. Br J Pharmacol 2007, 150:58-64.
130. Nogueiras R., Pfluger P., Tovar S., et al. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 2007, 148:21-26.
131. de Smet B., Thijs T., Peeters T.L., et al. Effects of peripheral obestatin on gastric emptying and intestinal contractility in rodents. Neurogastroenterol Motil 2007, 19:211-217.
132. Seoane L.M., Al-Massadi O., Pazos Y., et al. Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats. J Endocrinol Invest 2006, 29:RC13-RC15.
133. Zizzari P., Longchamps R., Epelbaum J., et al. Obestatin partially affects ghrelin stimulation on food intake and GH secretion in rodents. Endocrinology 2007, ahead of print January 4.
134. Samson W.K., White M., price C., et al. Obestatin acts in brain to inhibit thirst. Am J Physiol Regul Integr Comp Physiol 2007, 292:R637-R643.
135. Chartrel N., Alvear-Perez R., Leprince J., et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2007, 315:350-351.
136. Lauwers E., Lauduyt B., Arckens L., et al. Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun 2006, 351:21-25.
137. Tremblay F., Perreault M., Klaman L.D., et al. Normal food intake and body weight in mice lacking the orphan G protein-coupled receptor GPR39. Endocrinology 2007, 148:501-506.
138. Park W.H., Oh Y.J., Kim G.Y., et al. Obestatin is not elevated or correlated with insulin in children with Prader-Willi syndrome. J Endocrinol Metab 2007, 92:229-234.
139. Butler Mg, Bittel D.C. Plasma obestatin and ghrelin levels in subjects with Prader-Willi syndrome. Am J Med Gent A 2007, 143:415-421.
140. Pan W., Tu H., Kastin A.J. Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides 2006, 27:911-916.